Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8388013 | PMC |
| http://dx.doi.org/10.1161/HCQ.0000000000000099 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Comparison in the adult congenital heart disease severity classification of ACC/AHA and ESC guidelines in a 3,459 Mexican population.
Int J Cardiol Congenit Heart Dis
March 2024
Surgical and Medical Cardiovascular Specialties Direction, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico.
Background: Latin American registries of clinical and demographic profiles of ACHD are scarce. International guidelines classify disease complexity with different approaches. With these two regards, a registry was carried out to examine factors associated with mortality and to compare severity classifications in our population.
View Article and Find Full Text PDFValidation of ACC/AHA and ESC Sudden Cardiac Death Risk Guidelines in Diverse Hypertrophic Cardiomyopathy Cohort: Stratification HCM Study.
Glob Heart
December 2024
Instituto do Coração, Faculdade de Medicina Universidade de São Paulo, São Paulo, Brazil.
Background: Sudden cardiac death (SCD) is a major concern in patients with hypertrophic cardiomyopathy (HCM). The American College of Cardiology/American Heart Association (ACC/AHA) and the European Society of Cardiology (ESC) have different guidelines for SCD risk stratification. Their comparative performance in diverse populations remains uncertain.
View Article and Find Full Text PDFLong-term blood pressure control assessment using time spent in therapeutic range among Saudi patients.
Eur Rev Med Pharmacol Sci
December 2024
Pharmaceutical Analysis Department, King Abdullah International Medical Research Center (KAIMRC), Riyadh, Saudi Arabia.
Objective: Time in therapeutic range (TTR) is a new approach to monitoring blood pressure (BP), providing a more accurate picture over time compared to the standard single BP measurement during a clinic visit. Currently, no study from Saudi Arabia has explored the use of TTR in assessing BP control and its related factors. Thus, we aimed to investigate them in this study.
View Article and Find Full Text PDFEarly-stage hypertension defined by the 2017 ACC/AHA blood pressure guideline carries excessive cardiovascular risk in axial spondyloarthritis patients.
Ther Adv Musculoskelet Dis
November 2024
Department of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, New Territories 999077, Hong.
Background: Hypertension (HTN) is the most important modifiable risk factor for the development of cardiovascular events (CVEs). Patients with axSpA are also associated with an increased risk of future CVE.
Objectives: To ascertain whether baseline early-stage HTN is a predictor of future CVE in addition to inflammation in patients with axial spondyloarthritis (axSpA).
Imminent risk of LVEF decline in asymptomatic patients with primary mitral regurgitation.
Front Cardiovasc Med
October 2024
Division of Cardiovascular Disease, University of Alabama at Birmingham, Birmingham, AL, United States.
Article Synopsis
- The 2020 ACC/AHA Guidelines suggest that the optimal timing for mitral valve surgery in patients with primary mitral regurgitation occurs before left ventricular ejection fraction (LVEF) drops below 60% or left ventricular end-systolic dimension (LVESD) exceeds 40 mm, indicating the challenge of predicting surgical outcomes as patients approach these thresholds.
- Using machine learning and cardiac magnetic resonance (CMR) imaging, researchers studied the predictive capacity of specific CMR features (like LV sphericity index and strain rate) alongside traditional metrics to determine LVEF < 60% in asymptomatic patients over 18 months.
- The study involved 33 patients, revealing that those
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!